INSIGHTS ON DRUG DEVELOPMENT

• How A CDMO Overcomes Soft Gel Formulation Challenges

  Softgel development demands careful control of shell properties, liquid fills, and stability. Overcoming formulation challenges improves drug delivery, bioavailability, and shelf life.

• Quantification Of Semaglutide With A Reliable Analytical Method

  Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.

• AI Based Screening And Selection Of Co-Formers For Co-Crystallization

  Explore how AI and quantum chemistry are accelerating co-crystal screening and solving solubility challenges in drug development, as well as key technical considerations for identifying optimal co-formers.

• AI Enabled Pharmaceutical Cocrystal Screening

  Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.

• A Novel Patient-Derived Colorectal Cancer Organoid Platform

  4/22/2025

  Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

• Questions That Will Accelerate The Speed Of Your Program To Clinical

  9/23/2026

  The right early-stage strategy can prevent costly delays later. Explore key considerations for advancing programs to the clinic with confidence.

• An All-In-One Solution For Residual DNA Quantitation

  5/22/2025

  Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  4/14/2026

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection

  8/27/2025

  The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.